← Deal Flow

Oricell Therapeutics

Deep
1Rounds
0Articles
General InformationOricell Therapeutics is a biotech company focused on cellular and regenerative medicine solutions, likely operating in the longevity and advanced therapeutics space with a small to early-stage team composition.
Funding & FinancialsSpecific funding details for Oricell Therapeutics are not available in current public sources, suggesting the company may be in early-stage development or operating with limited public disclosure.
Leadership & TeamLeadership and executive team information for Oricell Therapeutics could not be confirmed from available sources, indicating either early-stage status or limited public presence.
Recent ActivityRecent developments or partnerships for Oricell Therapeutics are not readily available in public records, which is common for emerging biotech firms in stealth or early-development phases.

Highlights

Total Raised
1 rounds
Latest Round
$110
Apr 19, 2026
Stage
deep-tech
Employees
Headquarters
News Coverage
Talent Signals
SEC Filings

Backers

Beijing Medical and Health Care Industry Investment Fund
Elikon Investment
E-Town Capital
Luxin Venture Capital
NGS Super
Qiming Venture Partners
Talon Capital
Vivo Capital

Funding History

$110
2026
Pre-IPO
SEC Form D   Editorial
Apr 19, 2026
$110 millionPre-IPO · Editorial

Investors: Vivo Capital, Beijing Medical and Health Care Industry Investment Fund, Qiming Venture Partners, E-Town Capital, Luxin Venture Capital, NGS Super, Elikon Investment, Talon Capital

Chinese biotech developing CAR-T therapies for hepatocellular carcinoma raised $110M pre-IPO round on April 10, 2026.

Similar Companies 6